Clik here to view.
TOLVAPTAN …European Medicines Agency (EMA) Accepts Otsuka’s Marketing...
TOLVAPTAN N-(4-{[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide Formula C26H25ClN2O3 Mol. mass 448.941 g/mol 150683-30-0 CAS NO European...
View ArticleClik here to view.
Medicinal Chemistry International: NARLAPREVIR
Medicinal Chemistry International: NARLAPREVIRFiled under: Uncategorized Tagged: NARLAPREVIR
View ArticleClik here to view.
Duchenne Muscular Dystrophy: EspeRare Foundation And Drug Repositioning
Reblogged from : This is the fifth Blog Post in a series examining Duchenne Muscular Dystrophy (DMD) in the rare disease and orphan drug space. This Blog Post discusses the EspeRare Foundation and how...
View ArticleClik here to view.
MAROPITANT
MAROPITANT http://www.allfordrugs.com/2013/12/31/maropitant/Filed under: Uncategorized Tagged: MAROPITANT
View ArticleClik here to view.
GRANISETRON
GRANISETRON 1-methyl-N-((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide Nausea and Vomiting, Treatment of, Neurologic Drugs, 5-HT3 Antagonists 107007-99-8 hydrochloride...
View ArticleClik here to view.
Lorcaserin...Eisai Expands Marketing and Supply Agreement for Anti-obesity...
Reblogged from New Drug Approvals: (1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Eisai Expands Marketing and Supply Agreement for Anti-obesity Agent Lorcaserin to Include Most Countries...
View ArticleClik here to view.
TROPISETRON
TROPISETRON 89565-68-4 105826-92-4 (HCl) ICF 205-930, Navoban™ Molecular Formula: C17H20N2O2 Molecular Weight: 284.3529 Novartis (Originator) Tropisetron (INN) is a serotonin 5-HT3 receptor...
View ArticleClik here to view.
ALOSETRON HYDROCHLORIDE » All About Drugs
ALOSETRON HYDROCHLORIDE » All About DrugsFiled under: Uncategorized Tagged: ALOSETRON
View ArticleClik here to view.
GALDANSETRON » All About Drugs
GALDANSETRON » All About DrugsFiled under: Uncategorized Tagged: galdansetron
View ArticleClik here to view.
World Drug Tracker: LANEPITANT
World Drug Tracker: LANEPITANTFiled under: Uncategorized Tagged: LANEPITANT
View ArticleClik here to view.
Medicinal Chemistry International: PITANT SERIES
Medicinal Chemistry International: PITANT SERIESFiled under: Uncategorized Tagged: PITANT
View ArticleClik here to view.
TOSEDOSTAT ….An aminopeptidase inhibitor with antineoplastic activity.
TOSEDOSTAT An aminopeptidase inhibitor with antineoplastic activity. CHR 2797 CHR-2797 Tosedostat UNII-KZK563J2UW BB-76163Vernalis (Originator) CAS No. 238750-77-1 Chemical Name: Tosedostat Synonyms:...
View ArticleClik here to view.
TEDIZOLID (torezolid)
TEDIZOLID PHOSPHATE [(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-5-oxazolidinyl]methyl]phosphate, DA 7157 THERAPEUTIC CLAIM Treatment of complicated skin and skin...
View ArticleClik here to view.
Clik here to view.
World Drug Tracker: PLANTAIN THE SUPER MEDICINE WEED
World Drug Tracker: PLANTAIN THE SUPER MEDICINE WEED ………………………………………………………………………………………. THANKS AND REGARD’S DR ANTHONY MELVIN CRASTO Ph.D GLENMARK SCIENTIST , NAVIMUMBAI, INDIA did you feel happy, a...
View ArticleClik here to view.
Palbociclib
PALBOCICLIB Mechanism of action: selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 Indication: Estrogen receptor-positive (ER+), HER2-negative (HER2 -) breast cancer Current Status:...
View ArticleClik here to view.
Romosozumab (AMG 785) shines in phase II for osteoporosis
Romosozumab (AMG 785) Postmenopausal osteoporosis Romosozumab is a humanized monoclonal antibody that inhibits the action of sclerostin. It is being developed in collaboration with UCB for the...
View ArticleClik here to view.
World Drug Tracker: LEVOSIMENDAN – Oxygen Biotherapeutics Selects Duke...
World Drug Tracker: LEVOSIMENDAN – Oxygen Biotherapeutics Selects Duke Clinical Research Institute to Conduct Phase 3 Trial of Levosimendan LEVOSIMENDANFiled under: Uncategorized Tagged: LEVOSIMENDAN
View ArticleClik here to view.
NETUPITANT
NETUPITANT Ro 67-3189/000 UNII-7732P08TIR Ro-67-3189 Netupitant, an NK-1 antagonist is under development for the treatment of overactive bladder. HELSINN GROUP CAS: 290297-26-6 290296-54-7 (di HCl)...
View ArticleClik here to view.
World Drug Tracker: SOVAPREVIR in phase II clinical trials at Achillion for...
World Drug Tracker: SOVAPREVIR in phase II clinical trials at Achillion for the oral treatment of naive patients with chronic hepatitis C virus genotype 1Filed under: Uncategorized Tagged: sovaprevir
View Article